hematologic adverse events with adcs in breast cancer: optimal management strategies
Published 2 months ago • 10 plays • Length 5:00Download video MP4
Download video MP3
Similar videos
-
5:00
adc-related hematologic adverse events
-
6:30
managing pulmonary and cardiac adverse events related to adc therapy in breast cancer
-
4:00
adcs on the horizon for breast cancer: managing treatment-emergent toxicities
-
4:30
risk reduction and management protocols for gastrointestinal adverse events with adc therapy in b...
-
29:00
optimal sequencing of adcs in endocrine refractory hr /her2- metastatic breast cancer
-
29:00
optimal sequencing of adcs in endocrine refractory hr /her2- metastatic breast cancer
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
10:21
novel antibody-drug conjugates (adcs) technologies for management of mbc
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
2:21
adcs for the treatment of her2-low breast cancer
-
0:44
adcs in early breast cancer
-
2:07
emerging toxicities associated with adcs
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
2:02
dr. soliman the utility of adcs in breast cancer
-
18:19
collaborative management of atrial fibrillation in hematology patients
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
4:35
a multi-histology basket trial of ado-trastuzumab emtansine in patients with her2 amplified cancers
-
1:49
the latest clinical research on adcs in breast cancer